1 / 11

Subsidy for SPI Scheme 2025: Complete Guide for Pharma MSMEs & Clusters

Unlock the full benefits of the Subsidy for SPI Scheme 2025. Indiau2019s flagship support program for pharma MSMEs and clusters. This presentation explains APICF and RPTUAS subsidies, eligibility, funding limits, WHO-GMP and Schedule M compliance support, and how businesses can leverage the scheme to upgrade infrastructure and enhance global competitiveness. For more information: https://finraja.com/strengthening-of-pharmaceuticals-industry-spi-scheme/

Finraja
Télécharger la présentation

Subsidy for SPI Scheme 2025: Complete Guide for Pharma MSMEs & Clusters

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Subsidy for SPI Scheme 2025: Guide for Pharma MSMEs & Clusters For more information : https://finraja.com/strengthening-of-pharmaceuticals-industry-spi-scheme/

  2. Introduction • The Strengthening of Pharmaceuticals Industry (SPI) Scheme 2025 supports India’s pharma sector by boosting quality, enhancing global competitiveness, and enabling compliance with global standards like WHO-GMP and Revised Schedule M. • This guide helps you understand benefits, eligibility, and how to secure subsidies with expert support. For more information : https://finraja.com/strengthening-of-pharmaceuticals-industry-spi-scheme/

  3. Why SPI Scheme 2025 Matters • India is one of the world’s largest pharma producers. • Global markets demand quality, compliance, and upgraded infrastructure. • Subsidy for SPI Scheme 2025 helps MSMEs and clusters modernize, grow, and reduce compliance costs. For more information : https://finraja.com/strengthening-of-pharmaceuticals-industry-spi-scheme/

  4. Components of SPI Scheme 2025 The scheme has 3 major sub-schemes: • APICF: Assistance for Common Facilities • RPTUAS: Technology Upgradation & WHO-GMP Support • PMPDS: Promotion, Awareness & Industry Development For more information : https://finraja.com/strengthening-of-pharmaceuticals-industry-spi-scheme/

  5. APICF: Assistance to Pharmaceutical Industry for Common Facilities Supports creation of shared pharma infrastructure, including: • R&D labs • Testing labs • ETP/Influents • Training centres • Logistics hubs For more information : https://finraja.com/strengthening-of-pharmaceuticals-industry-spi-scheme/

  6. RPTUAS: Revamped Technology Upgradation Scheme Helps MSMEs upgrade facilities for: • WHO-GMP Certification • Revised Schedule M Compliance • Cleanrooms, HVAC, utilities • Testing labs & stability chambers • ETP & waste management For more information : https://finraja.com/strengthening-of-pharmaceuticals-industry-spi-scheme/

  7. PMPDS: Promotion & Development Scheme Supports: • Industry studies • Awareness programs • Exhibitions & expos • Database creation • Training workshops • Builds ecosystem visibility & capacity. For more information : https://finraja.com/strengthening-of-pharmaceuticals-industry-spi-scheme/

  8. Key Benefits of Subsidy for SPI Scheme 2025 Financial assistance for pharma clusters: • WHO-GMP & Schedule M upgrade support • Reduced cost of compliance • Access to testing & R&D infrastructure • Improved export readiness • Enhanced workforce skills For more information : https://finraja.com/strengthening-of-pharmaceuticals-industry-spi-scheme/

  9. Who can apply This scheme benefits: • MSME pharma manufacturers (<₹500 Cr turnover) • Pharma clusters & SPVs • Units upgrading to WHO-GMP / Schedule M • Facilities needing R&D labs or CETPs For more information : https://finraja.com/strengthening-of-pharmaceuticals-industry-spi-scheme/

  10. Why Finraja? • Finraja Consultancy Pvt. Ltd. provides: • Subsidy advisory • DPR preparation • Cluster formation support • Compliance & certification guidance (WHO-GMP, Schedule M) • Project appraisal support • Trusted by Pharma MSMEs, Formulation Units, API Units, Clusters & Associations. For more information : https://finraja.com/strengthening-of-pharmaceuticals-industry-spi-scheme/

  11. Contact Us • Finraja Consultancy Pvt. Ltd. • Phone: +91 9373114747 • Website: finraja.com/contact • For more information : https://finraja.com/strengthening-of-pharmaceuticals-industry-spi-scheme/ For more information : https://finraja.com/strengthening-of-pharmaceuticals-industry-spi-scheme/

More Related